Biological Terrorism: Is the Health Care Community Prepared?
February 11, 1999
Robin J. Strongin
With the nature of bioterrorism changing and biological agents joining more traditional methods in the public awareness, this Forum session used an Institute of Medicine study, "Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response," as a springboard for understanding the role the health care community must play in the event of a domestic biological terrorist attack. Speakers — focusing primarily on bioterrorism, as opposed to chemical or radiological terrorism — highlighted the issue of threat assessment and discussed ways to improve the level of preparedness as well as steps needed to convert the public health system into our best form of civil defense.
Margaret A. Hamburg, MD, Assistant Secretary for Planning and Evaluation, HHS; Scott R. Lillibridge, MD, Director, Bioterrorism Preparedness and Response, National Center for Infectious Diseases, Centers for Disease Control and Prevention; Donald A. Henderson, MD, MPH, Director, Center for Civilian Biodefense Studies, School of Hygiene and Public Health, Johns Hopkins Univeristy; Davi M. D'Agostino, Assistant Director, National Security and International Affairs Division, General Accounting Office; Jerome M. Hauer, Director, Mayor's Office of Emergency Management, New York City; Robert F. Knouss, MD, Director, Office of Emergency Preparedness, DHHS; Peter Rosen, MD, Professor of Clinical Medicine and Surgery, University of California, San Diego; Robert M. Blitzer, Associate Director, Center for Counterterrorism, Technology, and Analysis, Science Applications International Corproation, McLean, VA
More information available in the accompanying publication, Issue Brief No. 731.